Literature DB >> 9655258

Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration.

S Häggström1, P Wikström, A Bergh, J E Damber.   

Abstract

BACKGROUND: Angiogenesis is important for prostate organogenesis and prostate cancer progression. It is not yet known whether androgens promote part of their control of prostate structure and function by influencing angiogenesis. The aim of this study was to explore the possible androgenic regulation of the angiogenic factor vascular endothelial growth factor (VEGF) and its receptors flt-1 and flk-1/KDR in the rat ventral prostate (VP) and Dunning R3327 PAP adenocarcinoma.
METHODS: RNA was prepared from VP and tumors of intact and castrated rats. VEGF, flt-1, and flk-1/KDR mRNA levels were determined using competitive RT-PCR.
RESULTS: VEGF121, VEGF165, and VEGF189 together with flt-1 and flk-1/KDR mRNA were detected. The VEGF, but not flt-1 mRNA levels were significantly decreased in the VP after castration. The Dunning tumor expressed high levels of mRNA for VEGF and its receptors compared to the VP. The flt-1 mRNA level in the tumor increased after castration, while the VEGF mRNA levels were unchanged.
CONCLUSIONS: Decreased mRNA expression of VEGF, but not flt-1, was found in the rat VP after castration. However, in the Dunning tumor, castration did not alter the expression of VEGF mRNA. Moreover, elevated levels of both mRNA for VEGF and its receptors relative to the VP were observed, indicating that the VEGF system may be important for Dunning tumor development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655258     DOI: 10.1002/(sici)1097-0045(19980701)36:2<71::aid-pros1>3.0.co;2-h

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  6 in total

1.  Endothelial cells support the growth of prostate tissue in vivo.

Authors:  Michael Bates; Bruce Kovalenko; E Lynette Wilson; David Moscatelli
Journal:  Prostate       Date:  2008-06-01       Impact factor: 4.104

2.  Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.

Authors:  Kumar Nikhil; Lei Chang; Keith Viccaro; Max Jacobsen; Callista McGuire; Shakti R Satapathy; Michael Tandiary; Meaghan M Broman; Gregory Cresswell; Yizhou J He; George E Sandusky; Timothy L Ratliff; Dipanjan Chowdhury; Kavita Shah
Journal:  Cancer Lett       Date:  2019-02-01       Impact factor: 8.679

3.  Basic science of hormonal therapy for prostate cancer.

Authors:  D M Peehl
Journal:  Rev Urol       Date:  2001

4.  Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.

Authors:  Börje Ljungberg; Jan Jacobsen; Stina Häggström-Rudolfssson; Torgny Rasmuson; Gudrun Lindh; Kjell Grankvist
Journal:  Urol Res       Date:  2003-09-13

5.  Primary xenografts of human prostate tissue as a model to study angiogenesis induced by reactive stroma.

Authors:  Viviana P Montecinos; Alejandro Godoy; Jennifer Hinklin; R Robert Vethanayagam; Gary J Smith
Journal:  PLoS One       Date:  2012-01-31       Impact factor: 3.240

6.  Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.

Authors:  H J Chen; A T Treweeke; Y Q Ke; D C West; C H Toh
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.